United States

Profile: Cardiovascular Systems Inc (CSII.O)

CSII.O on Nasdaq

19 Jul 2019
Change (% chg)

$-0.16 (-0.36%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Cardiovascular Systems, Inc., incorporated on December 6, 2000, is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications. Its peripheral artery disease (PAD) systems are catheter-based platforms capable of treating a range of plaque types in leg arteries both above and below the knee. Its products include Diamondback 360 Peripheral Orbital Atherectomy System (OAS) (Diamondback 360 Peripheral), the Stealth 360 OAS (Stealth 360), Diamondback 360 Peripheral, Diamondback 360 60cm Peripheral, Diamondback 360 Low Profile Peripheral, Diamondback 360 1.50 Peripheral and Diamondback 360 2.00 Peripheral.

The Company's coronary arterial disease (CAD) product, Diamondback 360 Coronary OAS (Coronary OAS), is marketed as a treatment for severely calcified coronary arteries. The Coronary OAS design is similar to technology used in its Peripheral OAS, for the coronary application. The Company offers various accessory products required for use with the Peripheral and Coronary OAS. Its orbital atherectomy systems are used for treatment of PAD and CAD. The Peripheral OAS and Coronary OAS devices are single-use catheters that incorporate a control handle and flexible drive shaft with an offset diamond-coated crown. Its OAS uses a catheter that travels over its ViperWire guide wires and is powered by saline infusion pumps that also help cool the system and remove debris. The Peripheral OAS reduces plaque on peripheral vessel walls by using an orbiting, diamond-coated crown within peripheral arteries. Similarly, the Coronary OAS uses the same method to reduce severely calcified plaque on coronary vessel walls within coronary arteries in order to facilitate stent delivery. Its OAS components include Catheter; ViperWire Advance Peripheral Guide Wire, ViperWire Advance Peripheral Guide Wire with Flex Tip and ViperWire Advance Coronary Guide Wire; ViperSlide Lubricant, and OAS Pump.

The Company competes with Abbott Laboratories, Boston Scientific, Cook Medical, Johnson & Johnson, BARD, Medtronic Inc., Spectranetics and Philips.

Company Address

Cardiovascular Systems Inc

1225 Old Highway 8 NW
ST. PAUL   MN   55112-6416
P: +1651.2591600
F: +1612.6773355

Company Web Links